<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945581</url>
  </required_header>
  <id_info>
    <org_study_id>BK37</org_study_id>
    <nct_id>NCT00945581</nct_id>
  </id_info>
  <brief_title>Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery</brief_title>
  <official_title>Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives are to evaluate the effect of AN777 on muscle strength loss that&#xD;
      occurs during bed rest, and to investigate whether AN777, in association with resistance&#xD;
      training, will support muscle strength recovery following bed rest in healthy elderly&#xD;
      subjects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower extremity muscle strength changes after 10 days of bed rest, followed by changes after an 8-week recovery period.</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lower extremity lean body mass</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle functionality</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total lean mass</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity levels</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Aged</condition>
  <arm_group>
    <arm_group_label>AN777</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powder twice a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo powder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Powder twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Nutritional Powder Formula</intervention_name>
    <description>Powder twice a day</description>
    <arm_group_label>AN777</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo comparator</intervention_name>
    <description>Powder twice a day</description>
    <arm_group_label>Placebo powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject (male or female) is &gt; 60 to &lt; 79 years of age.&#xD;
&#xD;
          -  Subject has Body Mass Index (BMI)&gt; 20 &lt; 35.&#xD;
&#xD;
          -  Subject is ambulatory with an SPPB score of &gt; 9.&#xD;
&#xD;
          -  Subject agrees to comply with prescribed activity level.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has undergone major surgery, less than 4 weeks prior to enrollment in the&#xD;
             study.&#xD;
&#xD;
          -  Subject has stated active malignant disease, except basal or squamous cell skin&#xD;
             carcinoma or carcinoma in situ of the uterine cervix.&#xD;
&#xD;
          -  Subject has stated history of diabetes or fasting glucose value &gt; 126 mg/dL.&#xD;
&#xD;
          -  Subject has stated presence of partial or full artificial limb.&#xD;
&#xD;
          -  Subject has stated kidney disease or serum creatinine &gt; 1.4 mg/dL.&#xD;
&#xD;
          -  Subject has evidence of cardiovascular disease assessed during resting or exercise&#xD;
             EKG.&#xD;
&#xD;
          -  Subject has untreated hypothyroidism with TSH levels greater than 5.5 microUnits/ml.&#xD;
&#xD;
          -  Subject has serum glutamate pyruvate transaminase (SGPT) levels greater than two times&#xD;
             upper limit of laboratory-designated normal value.&#xD;
&#xD;
          -  Subject has a history of allergy to any of the ingredients in the study products.&#xD;
&#xD;
          -  Subject has an obstruction of the gastrointestinal tract precluding ingestion of the&#xD;
             study product, inflammatory bowel disease, short bowel syndrome or other major&#xD;
             gastrointestinal disease such as gastroesophageal reflux disease, gastroparesis,&#xD;
             peptic ulcer disease, celiac disease, intestinal dysmotility, diverticulitis, ischemic&#xD;
             colitis.&#xD;
&#xD;
          -  Subject has stated uncontrolled severe diarrhea, nausea or vomiting.&#xD;
&#xD;
        Subject is actively pursuing weight loss.&#xD;
&#xD;
          -  Subject is currently taking medications/dietary supplements/substances that could&#xD;
             modulate metabolism or weight in the opinion of the principal investigator or&#xD;
             physician, e.g. progestational agents, steroids, growth hormone, dronabinol,&#xD;
             marijuana, beta-hydroxyl-beta-methylbutyrate (HMB), free amino acid supplements,&#xD;
             dietary supplements to aid weight loss. Exceptions for multi-vitamin/mineral&#xD;
             supplement, inhaled steroids for asthma, topical or optical steroids and short-term&#xD;
             use (less than two weeks) of Dexamethasone.&#xD;
&#xD;
          -  Subject cannot refrain from smoking/discontinue the use of nicotine or tobacco.&#xD;
&#xD;
          -  Subject has a stated history of Deep Vein Thrombosis (DVT) or a known hypercoaguable&#xD;
             condition.&#xD;
&#xD;
          -  Subject cannot discontinue current anticoagulant therapy.&#xD;
&#xD;
          -  Subject has refractory anemia with hemoglobin value &lt; 11.5 g/dL.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzette Pereira, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <last_update_submitted>March 28, 2011</last_update_submitted>
  <last_update_submitted_qc>March 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2011</last_update_posted>
  <responsible_party>
    <name_title>Director Clinical Research Operations</name_title>
    <organization>Abbott Nutrition</organization>
  </responsible_party>
  <keyword>Healthy Elderly volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

